NRSN NeuroSense Therapeutics, Ltd. Kompaniya foydasi

NRSN (neurosense-tx.com) - kompaniyaning tovar belgisi

Daromadning yo'qligi va BAS testlari uchun xarajatlarning ortishi NeuroSense Therapeutics (NRSN) kompaniyasining operatsion richagini to'sib turibdi. Kompaniyaga tegishli umumiy foyda uning joriy bozor mavqeini aks ettiradi va oxirgi qiymat 0.00 deb qayd etilgan. Biznes moslashuvchanlikni saqlab qolish uchun tadqiqotlarni autsorsing qilishga tayanadi, kelajakdagi salohiyat esa molekula sertifikatsiyasidan keyin yuqori marjani va'da qiluvchi patentlar kengayuvchanligiga asoslangan.

Sof daromad: NeuroSense Therapeutics Ltd. (NRSN) 04.07.2022 - 29.10.2026 uchun

neurosense-tx.com (NRSN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi NeuroSense Therapeutics Ltd.|NRSN - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi NeuroSense Therapeutics|NRSN - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati NeuroSense Therapeutics|NRSN - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati neurosense-tx.com|NRSN - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati NeuroSense Therapeutics Ltd.|NRSN - Kompaniya qarzlari|Sof aktivlarga qarzlar NeuroSense Therapeutics|NRSN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz NeuroSense Therapeutics|Shoshilinch likvidlik koeffitsiyenti neurosense-tx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NRSN - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:NRSN - NeuroSense Therapeutics, Ltd.
NeuroSense Therapeutics tomonidan chiqariladigan mahsulotlar

ALS uchun PrimeC dorisini ishlab chiqayotgan NeuroSense Therapeutics (NRSN) uchun FDA tartibga soluvchi qarorlarini kutish davrlarida operatsion samaradorlik hal qiluvchi ahamiyatga ega. GURU.Markets instrumentlari to'rt choraklik hisobotlarning tekislovchi ta'sirisiz, kompaniyaning haqiqiy foydalari orqali kunlik sof daromadni vizuallashtirib, xarajatlar nazoratini real vaqt rejimida ochib beradi. Ushbu ko'rsatkichning barqaror o'sishi aktivlarning hayotiyligini tasdiqlaydi va potentsial M&A bitimlari uchun kompaniyaning investitsiyaviy jozibadorligini oshiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|Yakuniy foyda CPRX (catalystpharma.com)|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Amylyx Corp (AMLX) - Sof moliyaviy natija|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|PRTA - Kompaniyaning sof foydasi|Sof moliyaviy natija Alector, Inc. ALEC|ANNX: Sof foyda|Kompaniyaning sof daromadi Omeros (OMER)|Sof daromad NGNE|ACIU: Yakuniy foyda|Sof daromad VYGR (Voyager Pharma)|Soliqlar to‘langandan keyingi foyda NMRA|Sof foyda SCLX (Scilex Holding Company)|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|Kompaniyaning sof daromadi cogrx.com|Inhibikase (IKT) - Kompaniyaning sof foydasi|Cassava Pharma - Yakuniy foyda|ASRT (Assertio Holdings) - Sof foyda|Sof foyda Coya|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|OVID: Soliqdan keyingi foyda|Sof foyda ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Kompaniyaning sof daromadi|ATHE: Sof daromad|CLNN - Sof foyda|PEPG (pepgen.com) - Sof daromad|JUNS: Soliqlar to‘langandan keyingi foyda|RLMD (Relmada) - Sof foyda|Annovis Bio Corporation (ANVS) - Sof moliyaviy natija|Sof foyda GRCE|Sof daromad fireflyneuro.com AIFF|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Passage Bio - Yakuniy foyda|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Sof moliyaviy natija|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Kompaniyaning sof foydasi Alzamend Neuro ALZN|CYCN: Kompaniya foydasi|Protagenic - Sof foyda|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT (cortigent.com) - Sof daromad|Avenue Therapeutics Inc (ATXI) - Sof foyda|Kompaniyaning sof foydasi Brainstorm Cell|CARA: Yakuniy foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH: Kompaniya foydasi|Marinus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi nkgenbiotech.com|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Sage Therapeutics Inc. (SAGE) - Sof foyda|Kompaniyaning sof foydasi Neurotrope|TRVN: Yakuniy foyda|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE